With Bayer’s new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?

With Bayer’s new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
aliu
Tue, 03/01/2022 – 10:01